Guggenheim Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Guggenheim Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,119	Closed	-$304K	–	2142
2020 Q3	$304K	Sell	3,119 -629	-17%	-$72.4K	﹤0.01%	1630
2020 Q2	$460K	Sell	3,748 -3,578	-49%	-$406K	﹤0.01%	1468
2020 Q1	$641K	Sell	7,326 -1,615	-18%	-$171K	0.01%	1280
2019 Q4	$935K	Buy	8,941 +3,532	+65%	+$396K	0.01%	1367
2019 Q3	$622K	Sell	5,409 -71	-1%	-$10.8K	0.01%	1530
2019 Q2	$945K	Buy	5,480 +4,180	+322%	+$723K	0.01%	1379
2019 Q1	$219K	Buy	+1,300	New	+$193K	﹤0.01%	2034
2017 Q2	–	Sell	-15,935	Closed	-$1.93M	–	2885
2017 Q1	$1.93M	Sell	15,935 -4,917	-24%	-$603K	0.01%	1695
2016 Q4	$2.33M	Sell	20,852 -1,806	-8%	-$217K	0.01%	1556
2016 Q3	$3.01M	Sell	22,658 -1,063	-4%	-$102K	0.01%	1334
2016 Q2	$2.17M	Buy	23,721 +16,568	+232%	+$1.39M	0.01%	1510
2016 Q1	$516K	Buy	+7,153	New	+$392K	﹤0.01%	2356

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Guggenheim Capital's GWPH Position: Q4 2020 in Review

Guggenheim Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 3,119 shares — an estimated $304K sold.

Guggenheim Capital first reported a position in GWPH in Q1 2016 and held it in 12 quarters. The position peaked at $3.01M in Q3 2016. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

Guggenheim Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Guggenheim Capital sold 3,119 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $304K.
Guggenheim Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 12 quarters.
Guggenheim Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.01M in Q3 2016.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Guggenheim Capital's 13F filing for Q4 2020, filed 16 Feb 2021.